Sharing Knowledge

An Educational Resource to Improve Healthcare Safety

Mapping the Transmission of Resistant and Virulent Pathogens in the
High-Risk Operating Room Environment

Randy W. Loftus, MD

Program Description

This presentation will focus on a new technique that can proactively address transmission of pathogenic organisms in the OR. A review of the literature will confirm that bacterial pathogens are routinely transmitted in the operating room, and that transmission events are associated with increased patient morbidity and mortality. A summary of recent literature using technology to map the spread of S. aureus and ESKAPE pathogens will be discussed.  Lastly, there will be recommendations for the future of perioperative infection control.


For nurses to obtain credit click here

Ready for <USP 800>? The Next Chapter in Hazardous Drug Safety

For nurses to obtain credit click here

Seth Eisenberg, RN, OCN®

Professional Practice Coordinator

Fred Hutchinson Cancer Research Center and the Seattle Cancer Care Alliance

Seattle, WA

Marty Polovich, PhD, RN, AOCN®

Assistant Professor at the Byrdine F. Lewis School of Nursing & Health Professions

Georgia State University.


Program Description:

USP Chapter <800> is the most significant step forward for oncology nurse safety in years. The goal of this session is to provide an overview of the new standards and offer practical suggestions for managing the impact on oncology nursing practice. Successful implementation of the standards will require nurses to a) be familiar with the requirements of USP Chapter 800; b) recognize the need for new and ongoing HD education, training and competency; and c) evaluate and implement new safety equipment. Faculty will interact with attendees of this session through audience-response polling and a concluding question-and-answer session.


Learning Objectives:

At the conclusion of this session, attendees will be able to:

  1. List the adverse outcomes of occupational hazardous drug exposure.
  2. Describe the USP Chapter 800 standards that will impact oncology nursing practice related to hazardous drug safe handling.
  3. Describe the requirements for education and training of personnel who handle hazardous drugs.
  4. Discuss criteria to consider when selecting and implementing safety equipment for hazardous drug handling.

Protein Requirements in Protein-catabolic Critical Illness

L. John Hoffer, MD, PhD, FRCPC

Project Director, Lady Davis Institute for Medical Research. Senior Physician, Divisions of Internal Medicine and Endocrinology, Jewish General Hospital. Professor, Faculty of Medicine, McGill University. Associate Professor, School of Dietetics and Human Nutrition, McGill University


Program Description:

Although generous protein provision has long been recommended for ICU patients, the majority of them are severely protein undernourished. Some critical care experts now advise limiting all macronutrient provision to these patients. This presentation dissects the opposing recommendations, and outlines a paradigm for identifying patients who are most likely to benefit from generous protein provision.


Learning Objectives:

  1. Describe the current, contradictory recommendations regarding optimum protein provision in critical illness
  2. List factors to identify those patients who are most likely to benefit from optimal protein provision
  3. Describe a practical clinical paradigm for protein and energy provision.

Nurses, Dietitians: To obtain CEs for this program  click here

Accreditation Statement
Saxe Communications is  accredited as an provider of continuing nursing education.


Provider approved by the California Board of Registered Nursing. Provider # CEP 14477 for1.25 contact hours. This certificate must be retained by the licensee for a period of 4 years after the course is completed.


Provider approved by the Florida Board of Nursing. Provider # CE 50-17032 for 2.0 contact hours.

Giving Clinicians and Patients a Peripheral Advantage

After you have watched the video, you may go to and take the post-test. Upon successful completion, you may then print out your certificate.

Gregory J. Shears, MD

Lynn Hadaway, MED, RN-BC, CRNI®



Short peripheral IV catheters (PIVC), the most prevalent type of vascular access device (VAD), have high failure rates. Reasons are primarily related to site choices, insertion technique, and inappropriate device care during dwell. Additionally, insertion of PIVCs usually falls to clinicians with little or no formal education in this practice. To preserve peripheral veins, prevent unnecessary central VAD insertion, decrease costs, and improve satisfaction of clinicians and patients, change is certainly needed.


Recently, the use of pre-access assessment and optimal vein site choice has evolved to considering the intraluminal relationship of catheter tip to venous structures with the help of technology.  Catheter stabilization has also advanced to include strategies to optimize angulation, limit pressure injury and reduce catheter movement.  Together this comprehensive approach should help reduce PIVC failures by linking these pieces into a more complete best practice picture.


This interactive discussion will highlight the components of a comprehensive approach to improve these negative outcomes through education with competency assessment, pre-insertion assessment, and appropriate catheter management.


Learning Objectives:

  1. Identify best education and training practices for competency assessment.
  2. Analyze factors for choosing the most appropriate peripheral venous site.
  3. Evaluate methods for assessing the venous structure.
  4. Formulate the plan of care for PIVC management during the catheter dwell time.